Örebro University Hospital is a university hospital in Örebro, Sweden. The hospital is operated by Örebro County Council and took its current name in 2000, having previously been called Örebro Regional Hospital.

There are 462 (2015-02-06) beds in Örebro University Hospital.

During the past decade, Örebro University Hospital conducted 78 clinical trials. In the 10-year time frame, 78 clinical trials started and 12 clinical trials were completed, i.e. on average, 15.4% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 5 clinical trials were completed. i.e. 20.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Örebro University Hospital" #1 sponsor was "Region Örebro County" with 23 trials, followed by "Örebro University, Sweden" with 17 trials sponsored, "Uppsala University" with 15 trials sponsored, "Karolinska Institutet" with 12 trials sponsored and "Vastra Gotaland Region" with 12 trials sponsored. Other sponsors include 72 different institutions and companies that sponsored additional 67 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Örebro University Hospital" #1 collaborator was "Region Örebro County" with 15 trials as a collaborator, "Karolinska University Hospital" with 10 trials as a collaborator, "Skane University Hospital" with 8 trials as a collaborator, "University Hospital, Linkoeping" with 8 trials as a collaborator and "Uppsala University Hospital" with 8 trials as a collaborator. Other collaborators include 232 different institutions and companies that were collaborators in the rest 168 trials.

According to Clinical.Site data, the most researched conditions in "Örebro University Hospital" are "Prostate Cancer" (7 trials), "Atrial Fibrillation" (5 trials), "Breast Cancer" (4 trials), "Coronary Artery Disease" (4 trials) and "Acute Myocardial Infarction" (3 trials). Many other conditions were trialed in "Örebro University Hospital" in a lesser frequency.

Most popular intervention types in "Örebro University Hospital" are "Drug" (67 trials), "Other" (29 trials), "Procedure" (25 trials), "Device" (17 trials) and "Biological" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Rituximab" (4 trials), "Ibrutinib" (3 trials), "Morphine" (2 trials) and "Normal saline" (2 trials). Other intervention names were less common.

The vast majority of trials in "Örebro University Hospital" are 126 trials for "All" genders, 14 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Örebro University Hospital". undefined are not yet recruiting, 33 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 80 completed trials in Örebro University Hospital, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Örebro University Hospital, 4 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 19 trials, and there were also 49 trials that are defined as “Not Applicable".

Örebro University Hospital has several departments that took part in Clinical trials: "Department of Cardiology, Orebro University Hospital" - 7 trials, "Department of Cardio-thoracic and Vascular Surgery, Örebro University Hospital" - 4 trials, "Department of Surgery, Örebro University Hospital" - 2 trials, "Örebro University Hospital; Department of Gynecologic Oncology" - 2 trials, "Dept. of Orthopedic Surgery" - 2 trials